Skip to content
Screener

Baxter International BAX Reportable Segment — Intangible asset amortization expense

Other segment segments

Medical Products & Therapies
$51M+4.1%
Healthcare Systems & Technologies
$24M-11.1%
Pharmaceuticals
$16M0.0%

Similar metrics at other companies

Qualys, Inc. logo
QLYSReportable Segment — Intangible asset amortization expense
$640K0.0%
Kadant logo
KAIFlow Control — Intangible asset amortization expense
$1.27M-14.9%
Kadant logo
KAIIndustrial Processing — Intangible asset amortization expense
$4.43M+86.2%
Kadant logo
KAIMaterial Handling — Intangible asset amortization expense
$2.69M-5.0%
BellRing Brands logo
BRBRReportable Segment — Intangible Amortization
$4.2M0.0%
Powell Industries logo
POWLReportable Segment — Intangible Amortization
$223K

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: Baxter International’s 10-K, filed February 12, 2026.

Filed
Feb 12, 2026, 4:46 PM EST
Fiscal year
FY2025
Accession
0001628280-26-007733
for the years ended December 31 (in millions)202520242023
Total reportable segment operating income1,6331,7311,856
Other431818
Unallocated corporate costs(86)(275)(355)
Intangible asset amortization expense(598)(625)(590)
Business optimization items(178)(162)(174)
European Medical Devices Regulation(21)(33)(41)
Indefinite-lived asset impairments(290)(50)
Separation-related costs(58)

Item 8. Financial Statements and Supplementary Data.

FAQ

What is Baxter International's reportable segment — intangible asset amortization expense?
Baxter International (BAX) reported reportable segment — intangible asset amortization expense of -$149.5M in Q4 2025.
How has Baxter International's reportable segment — intangible asset amortization expense changed year-over-year?
Baxter International's reportable segment — intangible asset amortization expense increased by 4.3% year-over-year, from -$156.25M to -$149.5M.
What is the long-term trend for Baxter International's reportable segment — intangible asset amortization expense?
Over 3 years (2022 to 2025), Baxter International's reportable segment — intangible asset amortization expense has grown at a -4.1% compound annual growth rate (CAGR), from -$679M to -$598M.
What does reportable segment — intangible asset amortization expense mean?
This represents the systematic allocation of the cost of intangible assets, such as patents, trademarks, and acquired technology, over their estimated useful lives. It is a non-cash expense that reflects the consumption of the economic value of acquired intellectual property.

Ask your AI about Baxter International's reportable segment — intangible asset amortization expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude